|
|
| | NSC 299195 Basic information |
| Product Name: | NSC 299195 | | Synonyms: | Mitoxantrone (diacetate);NSC 299195;2-[[5,8-dihydroxy-4-[2-(2-hydroxyethylazaniumyl)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl-(2-hydroxyethyl)azanium:diacetate | | CAS: | 70711-41-0 | | MF: | C24H32N4O8 | | MW: | 504.54 | | EINECS: | | | Product Categories: | | | Mol File: | 70711-41-0.mol |  |
| | NSC 299195 Chemical Properties |
| | NSC 299195 Usage And Synthesis |
| Description | Mitoxantrone diacetate is an anthraquinone that intercalates in DNA and inhibits topoisomerase II. | | Uses | Mitoxantrone diacetate is a potent topoisomerase II inhibitor. Mitoxantrone diacetate also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone diacetate induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone diacetate shows antitumor activity[1][2][3][4]. Mitoxantrone diacetate also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively[5]. | | in vivo | Mitoxantrone diacetate (IP, 0-3.2 mg/kg/day) produces a statistically significant number of 60-day survivors at 1.6 mg/kg in mice with IP implanted L1210 leukemia[4].
Mitoxantrone diacetate (IV, 0-3.2 mg/kg/day) shows effective antitumor activities and produces a 60% ILS (increase in lifespan) at 3.2 mg/kg in SC implanted Lewis lung carcinoma[4]. | | IC 50 | Topoisomerase II; PKC: 8.5 μM (IC50) | | References | [1] Takeuchi N, et al. Inhibitory effect of mitoxantrone on activity of protein kinase C and growth of HL60 cells. J Biochem. 1992 Dec;112(6):762-7. DOI:10.1093/oxfordjournals.jbchem.a123972
[2] Bellosillo B, et al. Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol. 1998 Jan;100(1):142-6. DOI:10.1046/j.1365-2141.1998.00520.x
[3] Vibet S, et al. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines. Drug Metab Dispos. 2007 May;35(5):822-8. DOI:10.1124/dmd.106.013474
[4] Fujimoto S, et al. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics. Cancer Chemother Pharmacol. 1982;8(2):157-62. DOI:10.1007/BF00255476
[5] Sharon E Altmann, et al. Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone. Antiviral Res. 2012 Feb;93(2):305-308. DOI:10.1016/j.antiviral.2011.12.001 |
| | NSC 299195 Preparation Products And Raw materials |
|